CSIMarket
 


Resmed Inc  (RMD)
Other Ticker:  
 
 

RMD's EPS Net Growth by Quarter and Year

Resmed Inc's EPS Net results by quarter and year




RMD EPS Net (in $) FY 2019 FY 2018 FY 2017 FY 2016
IV Quarter June 0.47 0.22 0.62 0.63
III Quarter March 0.73 0.76 0.54 0.64
II Quarter December 0.86 0.60 0.54 0.57
I Quarter September 0.73 0.71 0.65 0.61
FY   2.79 2.29 2.35 2.45



RMD EPS Net forth quarter 2019 Y/Y Growth Comment
Resmed Inc achieved in the forth quarter, above Company average EPS Net surge of 115.34% year on year, to $ 0.47 .

Looking into forth quarter results within Medical Equipment & Supplies industry 10 other companies have achieved higher EPS Net growth. While Resmed Inc' s EPS Net doubling of 115.34% ranks overall at the positon no. 407 in the forth quarter.




RMD EPS Net ( Y/Y Growth %) 2019
2018 2017 2016
IV Quarter June 115.34 % -64.52 % -1.59 % -1.56 %
III Quarter March -3.95 % 40.74 % -15.63 % 0 %
II Quarter December 43.33 % 11.11 % -5.26 % -1.72 %
I Quarter September 2.82 % 9.23 % 6.56 % 0 %
FY   22 % -2.55 % -4.08 % -

Financial Statements
Resmed Inc's forth quarter 2019 EPS Net $ 0.47 RMD's Income Statement
Resmed Inc's forth quarter 2018 EPS Net $ 0.22 Quarterly RMD's Income Statement
New: More RMD's historic EPS Net Growth >>


RMD EPS Net (Quarter on Quarter Growth %)

2019
2018 2017 2016
IV Quarter June -35.1 % -71.05 % 14.81 % -1.56 %
III Quarter March -15.12 % 26.67 % 0 % 12.28 %
II Quarter December 17.81 % -15.49 % -16.92 % -6.56 %
I Quarter September 231.82 % 14.52 % 3.17 % -4.69 %
FY (Year on Year)   22 % -2.55 % -4.08 % -




EPS Net forth quarter 2019 Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #11
Healthcare Sector #40
Overall #407

EPS Net Y/Y Growth Statistics
High Average Low
11.27 % 0.95 % -15 %
(Dec 31 2018)   (Jun 30 2018)
EPS Net forth quarter 2019 Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #11
Healthcare Sector #40
Overall #407
EPS Net Y/Y Growth Statistics
High Average Low
11.27 % 0.95 % -15 %
(Dec 31 2018)   (Jun 30 2018)

EPS Net by Quarter for the Fiscal Years 2016, 2017, 2018, 2019

Resmed Inc's Q/Q EPS Net Growth


EPS Net Q/Q Growth Statistics
High Average Low
10716.33 % 448.7 % -100 %
(Dec 31 2012)  


RMD's IV. Quarter Q/Q EPS Net Comment
In the IV. Quarter 2019 Resmed Inc disclosed fall in EPS Net from the third quarter by -35.1% to $ 0.47 , from $ 0.73 released in the previous reporting period.

It's not big problem, as IV. Quarter EPS Net generally tend to plunge in this quarter Rachel Reed, a business contributor situated in Houston wrote.

Within Medical Equipment & Supplies industry 27 other companies have achieved higher EPS Net quarter on quarter growth. While Resmed Inc's EPS Net growth quarter on quarter, overall rank is 1306.


EPS Net Q/Q Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #28
Healthcare Sector #83
Overall #1306
EPS Net Q/Q Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #28
Healthcare Sector #83
Overall #1306
EPS Net Q/Q Growth Statistics
High Average Low
10716.33 % 448.7 % -100 %
(Dec 31 2012)  


RMD's IV. Quarter Q/Q EPS Net Comment
In the IV. Quarter 2019 Resmed Inc reported fall in EPS Net sequentially by -35.1% to $ 0.47 , from $ 0.73 achived in the previous reporting period.

As we look into current downturn in the IV. Quarter 2019, we suppose to presume, that frequently IV. Quarter 2019 results occur softer then in the quarter before

Within Medical Equipment & Supplies industry 27 other companies have achieved higher EPS Net quarter on quarter growth. While Resmed Inc's EPS Net growth quarter on quarter, overall rank is 1306.


Resmed Inc's 12 Months EPS Net Growth Year on Year


EPS Net TTM Growth

12 Months Ending
(Jun 30 2019)
12 Months Ending
(Mar 31 2019)
12 Months Ending
(Dec 31 2018)
12 Months Ending
(Sep 30 2018)
12 Months Ending
(Jun 30 2018)
Cumulative EPS Net 12 Months Ending $ 2.79 $ 2.54 $ 2.57 $ 2.31 $ 2.29
Y / Y EPS Net Growth (TTM) 22.14 % -5.75 % 3.85 % -4.35 % -2.78 %
Year on Year EPS Net Growth Overall Ranking # 706 # 1138 # 89 # 1336 # 1131
Seqeuential EPS Net Change (TTM) 10.15 % -1.17 % 11.27 % 0.83 % -15 %
Seq. EPS Net Growth (TTM) Overall Ranking # 407 # 1132 # 127 # 671 # 1732




Cumulative EPS Net growth Comment
Resmed Inc saw improvement in EPS Net growth trend, posting cumulative 12 months EPS Net growth of 22.14% year on year, to $ 3 if the fiscal year would have ended in Jun 30 2019.
Resmed Inc's trailing twelve months EPS Net growth was higher than company's average -2.56% and higher than -5.75% growth in Mar 31 2019.
But from the previous reporting period increase was less at 10.15 % from $2.54 reported in twelve months ending a quarter before.
Still this was evidence of convincing trend, while the average Q/Q TTM advancement is at 0.95%.
The growth was even more impressive from the previous reporting period clinched at 10.15 % rise from $2.54 in the period from Mar 31 2019 to Jun 30 2018.

In the Healthcare sector 53 other companies have achieved higher trailing twelve month EPS Net growth. While Total ranking has impoved so far to 706, from total ranking in previous quarter at 1138.

EPS Net TTM Q/Q Growth Statistics
High Average Low
11.27 %
0.95 %
-15 %
 

EPS Net TTM Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 11
Healthcare Sector # 54
Overall # 706

EPS Net TTM Y/Y Growth Statistics
High Average Low
121.75 %
-2.56 %
-95.46 %
 


EPS Net TTM Q/Q Growth Company Ranking
Within: No.
Industry # 11
Sector # 40
S&P 500 # 407
Cumulative EPS Net growth Comment
Resmed Inc saw improvement in EPS Net growth trend, posting cumulative 12 months EPS Net growth of 22.14% year on year, to $ 3 if the fiscal year would have ended in Jun 30 2019.
Resmed Inc's trailing twelve months EPS Net growth was higher than company's average -2.56% and higher than -5.75% growth in Mar 31 2019.
But from the previous reporting period rise was slower at 10.15 % from $2.54 recorded in twelve months ending a quarter Mar 31 2019 Rachel Reed went on.
Yet it was validation of strength, as the typical sequential EPS Net gain stands at 0.95%.
The momentum was much stronger from the previous reporting period showed at 10.15 % rise from $2.54 in twelve months ending a quarter Mar 31 2019.

In the Healthcare sector 53 other companies have achieved higher trailing twelve month EPS Net growth. While Total ranking has impoved so far to 706, from total ranking in previous quarter at 1138.

EPS Net TTM Q/Q Growth Statistics
High Average Low
11.27 %
0.95 %
-15 %
 


EPS Net TTM Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 11
Healthcare Sector # 54
Overall # 706

EPS Net TTM Y/Y Growth Statistics
High Average Low
121.75 %
-2.56 %
-95.46 %
 


EPS Net TTM Q/Q Growth Company Ranking
Within: No.
Industry # 11
Sector # 40
S&P 500 # 407




Other EPS Net Growth
Medical Equipment & Supplies Industry EPS Net Growth Trends and Statistics
Healthcare Sector EPS Net Growth Statistics
EPS Net Growth Trends for overall market
RMD's EPS Net Growth Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking EPS Net Growth
Lowest Ranking EPS Net Growth
EPS Net Growth for RMD's Competitors
EPS Net Growth for Resmed Inc's Suppliers
EPS Net Growth for RMD's Customers

You may also want to know
RMD's Annual Growth Rates RMD's Profitability Ratios RMD's Asset Turnover Ratio RMD's Dividend Growth
RMD's Roe RMD's Valuation Ratios RMD's Financial Strength Ratios RMD's Dividend Payout Ratio
RMD's Roa RMD's Inventory Turnover Ratio RMD's Growth Rates RMD's Dividend Comparisons



Companies with similar EPS Net fall for the quarter ending Jun 30 2019 within Healthcare SectorY/Y Change %EPS Net for the quarter ending Jun 30 2019
Lifeloc Technologies, Inc  200.00 %$ 200.000 
Repligen Corp  183.33 %$ 183.333 
Eagle Pharmaceuticals, Inc.  182.35 %$ 182.353 
Integra Lifesciences Holdings Corp  142.86 %$ 142.857 
Vanda Pharmaceuticals Inc.  133.33 %$ 133.333 
Ani Pharmaceuticals Inc  130.43 %$ 130.435 
Bio-rad Laboratories, Inc.  123.90 %$ 123.901 
Resmed Inc  119.11 %$ 119.113 
Incyte Corp  100.00 %$ 100.000 
Staar Surgical Co  100.00 %$ 100.000 
Biogen Inc.  87.80 %$ 87.799 
Genomic Health, Inc  82.61 %$ 82.609 
Semler Scientific, Inc.  68.42 %$ 68.421 
Merck & Co., Inc.  63.49 %$ 63.492 
Medpace Holdings, Inc.  62.22 %$ 62.222 


             
Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

BASI's Profile

Stock Price

BASI's Financials

Business Description

Fundamentals

Charts & Quotes

BASI's News

Suppliers

BASI's Competitors

Customers & Markets

Economic Indicators

BASI's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Indices

Sectors & Industries

Financials

Commodities

Currencies

News


At a Glance

Stocks

Economy

Industries

Other

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.  Free Stock Market News Feeds
   Copyright © 2019 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

To view Intraday Stock Data Java must be installed. Java content may be prohibited by the security software, to see the stock quotes, choose "allow content from this page" option. Stock Price, historical and current end-of-day data provided by eoddata. Intraday data delayed per exchange requirements. S&P/Dow Jones Indices (SM) from Barchart and Eoddata. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071